Immunology of Infectious Disease News Volume 8.30 | Aug 12 2020

    0
    13






    IIDN 8.30 | Aug 12


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 8.30 – 12 August, 2020
    TOP STORY

    Phase I/II Study of COVID-19 RNA Vaccine BNT162b1 in Adults

    Scientists report the available safety, tolerability, and immunogenicity data from an ongoing placebo-controlled, observer-blinded dose escalation study among 45 healthy adults, 18 to 55 years of age, randomized to receive two doses, separated by 21 days, of 10 µg, 30 µg, or 100 µg of BNT162b1, a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine that encoded trimerized SARS-CoV-2 spike glycoprotein receptor-binding domain.
    [Nature]

    AbstractFull Article
    Find the Right Antibodies For Your Stem Cell Research. Learn More
    PUBLICATIONSRanked by the impact factor of the journal

    Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

    In a dual-center, two-cohort study, researchers combined single-cell RNA-sequencing and single-cell proteomics of whole blood and peripheral blood mononuclear cells to determine changes in immune cell composition and activation in mild vs. severe COVID-19 over time.
    [Cell]

    Full Article

    Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

    Investigators experimentally measured how all amino-acid mutations to the receptor binding protein affect expression of folded protein and its affinity for ACE2.
    [Cell]

    AbstractFull Article

    Single-Cell Landscape of Immunological Responses in Patients with COVID-19

    Scientists performed single-cell RNA sequencing in peripheral blood samples of five healthy donors and 13 patients with COVID-19, including moderate, severe and convalescent cases.
    [Nature Immunology]

    Full Article

    Complement and Tissue Factor-Enriched Neutrophil Extracellular Traps Are Key Drivers in COVID-19 Immunothrombosis

    The authors investigated how complement interacted with the platelet/neutrophil extracellular traps (NETS)/thrombin axis, using COVID-19 specimens, cell-based inhibition studies and NETs/human aortic endothelial cell co-cultures.
    [Journal of Clinical Investigation]

    AbstractFull Article

    Single-Cell Analysis of Two Severe COVID-19 Patients Reveals a Monocyte-Associated and Tocilizumab-Responding Cytokine Storm

    By employing single-cell analysis of the immune cell composition of two severe-stage COVID-19 patients prior to and following tocilizumab-induced remission, investigators identified a monocyte subpopulation that contributes to the inflammatory cytokine storms.
    [Nature Communications]

    Full Article

    Inhibition of PIKfyve Kinase Prevents Infection by Zaire Ebolavirus and SARS-CoV-2

    Scientists describe potent inhibitory effects on content release and infection by chimeric vesicular stomatitis virus containing the envelope proteins of Zaire ebolavirus or SARS-CoV-2 elicited by Apilimod and Vacuolin-1, small-molecule inhibitors of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

    Researchers report on a systems-level blood immunomonitoring study of 37 adult patients diagnosed with COVID-19 and followed with up to 14 blood samples from acute to recovery phases of the disease.
    [Cell Reports Medicine]

    AbstractFull ArticleGraphical Abstract

    Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells

    The ability of immune mobilizing monoclonal T cell receptors Against Virus-envelope to activate and redirect polyclonal T cells towards cells containing integrated HBV and cells infected with hepatitis B virus was assessed using cytokine secretion assays and imaging‐based killing assays.
    [Hepatology]

    Abstract

    Inhibition of Mitophagy Drives Macrophage Activation and Anti-bacterial Defense during Sepsis

    Scientists showed that lipopolysaccharide in combination with IFNγ, inhibited PINK1-dependent mitophagy in macrophages through a STAT1-dependent activation of the inflammatory caspases 1 and 11.
    [Journal of Clinical Investigation]

    AbstractFull Article

    Bacterial Polyphosphates Interfere with the Innate Host Defense to Infection

    The authors report that mouse survival of peritoneal Escherichia coli sepsis was compromised by long-chain polyphosphates, and improved with bacterial polyphosphatekinase deficiency or neutralization using recombinant exopolyphosphatase.
    [Nature Communications]

    Full Article

    Rapid Antiretroviral Therapy among Individuals with Acute and Early HIV

    Researchers show rapid antiretroviral therapy in acute and early HIV was acceptable and effective, with 69.0% of participants starting ART within seven days of HIV diagnosis disclosure and 88.1% achieving suppression by 48 weeks.
    [Clinical Infectious Diseases]

    Abstract

    Salmonella enterica Serovar Typhi Exposure Elicits Ex Vivo Cell-Type-Specific Epigenetic Changes in Human Gut Cells

    Typhi strain were stained with a 33-metal-labeled antibody panel for mass cytometry analyses of the early chromatin modifications modulated by S. Typhi.
    [Scientific Reports]

    Full Article

    Who does immunology research in the Bolivian Andes? He does. Read Jason Young's story.
    REVIEWS

    Immunometabolism and HIV-1 Pathogenesis: Food for Thought

    The authors summarize current knowledge of the links between HIV-1 infection and immunometabolism, and they discuss the potential opportunities and challenges for therapeutic interventions.
    [Nature Reviews Immunology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Russia’s Fast-Track Coronavirus Vaccine Draws Outrage Over Safety

    Russia’s president Vladimir Putin announced that the country’s health regulator had become the world’s first to approve a coronavirus vaccine for widespread use – but scientists worldwide have condemned the decision as dangerously rushed.
    [Nature News]

    Press Release

    RedHill Biopharma’s Phase II/III COVID-19 Study Approved in Mexico

    RedHill Biopharma Ltd. announced approval from the Mexican Federal Committee for the Protection against Sanitary Risks for the company’s Clinical Trial Authorization application for the Phase II/III study evaluating opaganib in patients hospitalized with severe SARS-CoV-2 infection and pneumonia.
    [RedHill Biopharma Ltd.]

    Press Release

    BioAegis Therapeutics Initiates Phase II Clinical Trial of Its Inflammation Regulator, Gelsolin, for COVID-19 Treatment

    BioAegis Therapeutics, Inc. announced that it enrolled its first patient in its Phase II study of hospitalized patients with severe COVID-19 pneumonia.
    [BioAegis Therapeutics, Inc. (GlobeNewswire, Inc.)]

    Press Release

    IMV Receives Funding from Canadian Governmental Agencies for COVID-19 Vaccine Phase I Clinical Study

    IMV, Inc. announced that Canadian government agencies will contribute up to CA$4.75 million to advance Phase I clinical development of its vaccine candidate, DPX-COVID-19, for the prevention of COVID-19 infection caused by the novel coronavirus SARS-COV-2.
    [IMV, Inc.]

    Press Release

    Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

    Novavax, Inc. and Takeda Pharmaceutical Company Limited announced a partnership for the development, manufacturing and commercialization of NVX‑CoV2373, Novavax’ COVID‑19 vaccine candidate, in Japan.
    [Novavax, Inc.]

    Press Release

    US Food and Drug Administration Approves Lampit® (Nifurtimox) for the Treatment of Chagas Disease in Children

    Bayer announced that the FDA has approved Lampit® for use in pediatric patients for the treatment of Chagas disease caused by Trypanosoma cruzi.
    [Bayer (BusinessWire, Inc.)]

    Full Article

    FEATURED EVENT

    Virtual Meeting: Translational Immunology

    September 16
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Assistant Professor – Immunology Research

    Princeton University – Princeton, New Jersey, United States

    Postdoctoral Fellow – Bacterial Pathogens and Immune Response

    Rush University Medical Center – Chicago, Illinois, United States

    Postdoctoral Researcher – Intestinal Immune Responses to Infection

    University of Dundee – Dundee, United Kingdom

    Research Group Leader – Microbiology, Virology and Infection Epidemiology

    University of Würzburg – Würzburg, Germany

    Research Scientist – SARS-CoV-2 Vaccine Development

    Ohio State University – Columbus, Ohio, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter






    IIDN 8.30 | Aug 12


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 8.30 – 12 August, 2020
    TOP STORY

    Phase I/II Study of COVID-19 RNA Vaccine BNT162b1 in Adults

    Scientists report the available safety, tolerability, and immunogenicity data from an ongoing placebo-controlled, observer-blinded dose escalation study among 45 healthy adults, 18 to 55 years of age, randomized to receive two doses, separated by 21 days, of 10 µg, 30 µg, or 100 µg of BNT162b1, a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine that encoded trimerized SARS-CoV-2 spike glycoprotein receptor-binding domain.
    [Nature]

    AbstractFull Article
    Find the Right Antibodies For Your Stem Cell Research. Learn More
    PUBLICATIONSRanked by the impact factor of the journal

    Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

    In a dual-center, two-cohort study, researchers combined single-cell RNA-sequencing and single-cell proteomics of whole blood and peripheral blood mononuclear cells to determine changes in immune cell composition and activation in mild vs. severe COVID-19 over time.
    [Cell]

    Full Article

    Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

    Investigators experimentally measured how all amino-acid mutations to the receptor binding protein affect expression of folded protein and its affinity for ACE2.
    [Cell]

    AbstractFull Article

    Single-Cell Landscape of Immunological Responses in Patients with COVID-19

    Scientists performed single-cell RNA sequencing in peripheral blood samples of five healthy donors and 13 patients with COVID-19, including moderate, severe and convalescent cases.
    [Nature Immunology]

    Full Article

    Complement and Tissue Factor-Enriched Neutrophil Extracellular Traps Are Key Drivers in COVID-19 Immunothrombosis

    The authors investigated how complement interacted with the platelet/neutrophil extracellular traps (NETS)/thrombin axis, using COVID-19 specimens, cell-based inhibition studies and NETs/human aortic endothelial cell co-cultures.
    [Journal of Clinical Investigation]

    AbstractFull Article

    Single-Cell Analysis of Two Severe COVID-19 Patients Reveals a Monocyte-Associated and Tocilizumab-Responding Cytokine Storm

    By employing single-cell analysis of the immune cell composition of two severe-stage COVID-19 patients prior to and following tocilizumab-induced remission, investigators identified a monocyte subpopulation that contributes to the inflammatory cytokine storms.
    [Nature Communications]

    Full Article

    Inhibition of PIKfyve Kinase Prevents Infection by Zaire Ebolavirus and SARS-CoV-2

    Scientists describe potent inhibitory effects on content release and infection by chimeric vesicular stomatitis virus containing the envelope proteins of Zaire ebolavirus or SARS-CoV-2 elicited by Apilimod and Vacuolin-1, small-molecule inhibitors of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

    Researchers report on a systems-level blood immunomonitoring study of 37 adult patients diagnosed with COVID-19 and followed with up to 14 blood samples from acute to recovery phases of the disease.
    [Cell Reports Medicine]

    AbstractFull ArticleGraphical Abstract

    Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells

    The ability of immune mobilizing monoclonal T cell receptors Against Virus-envelope to activate and redirect polyclonal T cells towards cells containing integrated HBV and cells infected with hepatitis B virus was assessed using cytokine secretion assays and imaging‐based killing assays.
    [Hepatology]

    Abstract

    Inhibition of Mitophagy Drives Macrophage Activation and Anti-bacterial Defense during Sepsis

    Scientists showed that lipopolysaccharide in combination with IFNγ, inhibited PINK1-dependent mitophagy in macrophages through a STAT1-dependent activation of the inflammatory caspases 1 and 11.
    [Journal of Clinical Investigation]

    AbstractFull Article

    Bacterial Polyphosphates Interfere with the Innate Host Defense to Infection

    The authors report that mouse survival of peritoneal Escherichia coli sepsis was compromised by long-chain polyphosphates, and improved with bacterial polyphosphatekinase deficiency or neutralization using recombinant exopolyphosphatase.
    [Nature Communications]

    Full Article

    Rapid Antiretroviral Therapy among Individuals with Acute and Early HIV

    Researchers show rapid antiretroviral therapy in acute and early HIV was acceptable and effective, with 69.0% of participants starting ART within seven days of HIV diagnosis disclosure and 88.1% achieving suppression by 48 weeks.
    [Clinical Infectious Diseases]

    Abstract

    Salmonella enterica Serovar Typhi Exposure Elicits Ex Vivo Cell-Type-Specific Epigenetic Changes in Human Gut Cells

    Typhi strain were stained with a 33-metal-labeled antibody panel for mass cytometry analyses of the early chromatin modifications modulated by S. Typhi.
    [Scientific Reports]

    Full Article

    Who does immunology research in the Bolivian Andes? He does. Read Jason Young's story.
    REVIEWS

    Immunometabolism and HIV-1 Pathogenesis: Food for Thought

    The authors summarize current knowledge of the links between HIV-1 infection and immunometabolism, and they discuss the potential opportunities and challenges for therapeutic interventions.
    [Nature Reviews Immunology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Russia’s Fast-Track Coronavirus Vaccine Draws Outrage Over Safety

    Russia’s president Vladimir Putin announced that the country’s health regulator had become the world’s first to approve a coronavirus vaccine for widespread use – but scientists worldwide have condemned the decision as dangerously rushed.
    [Nature News]

    Press Release

    RedHill Biopharma’s Phase II/III COVID-19 Study Approved in Mexico

    RedHill Biopharma Ltd. announced approval from the Mexican Federal Committee for the Protection against Sanitary Risks for the company’s Clinical Trial Authorization application for the Phase II/III study evaluating opaganib in patients hospitalized with severe SARS-CoV-2 infection and pneumonia.
    [RedHill Biopharma Ltd.]

    Press Release

    BioAegis Therapeutics Initiates Phase II Clinical Trial of Its Inflammation Regulator, Gelsolin, for COVID-19 Treatment

    BioAegis Therapeutics, Inc. announced that it enrolled its first patient in its Phase II study of hospitalized patients with severe COVID-19 pneumonia.
    [BioAegis Therapeutics, Inc. (GlobeNewswire, Inc.)]

    Press Release

    IMV Receives Funding from Canadian Governmental Agencies for COVID-19 Vaccine Phase I Clinical Study

    IMV, Inc. announced that Canadian government agencies will contribute up to CA$4.75 million to advance Phase I clinical development of its vaccine candidate, DPX-COVID-19, for the prevention of COVID-19 infection caused by the novel coronavirus SARS-COV-2.
    [IMV, Inc.]

    Press Release

    Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

    Novavax, Inc. and Takeda Pharmaceutical Company Limited announced a partnership for the development, manufacturing and commercialization of NVX‑CoV2373, Novavax’ COVID‑19 vaccine candidate, in Japan.
    [Novavax, Inc.]

    Press Release

    US Food and Drug Administration Approves Lampit® (Nifurtimox) for the Treatment of Chagas Disease in Children

    Bayer announced that the FDA has approved Lampit® for use in pediatric patients for the treatment of Chagas disease caused by Trypanosoma cruzi.
    [Bayer (BusinessWire, Inc.)]

    Full Article

    FEATURED EVENT

    Virtual Meeting: Translational Immunology

    September 16
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Assistant Professor – Immunology Research

    Princeton University – Princeton, New Jersey, United States

    Postdoctoral Fellow – Bacterial Pathogens and Immune Response

    Rush University Medical Center – Chicago, Illinois, United States

    Postdoctoral Researcher – Intestinal Immune Responses to Infection

    University of Dundee – Dundee, United Kingdom

    Research Group Leader – Microbiology, Virology and Infection Epidemiology

    University of Würzburg – Würzburg, Germany

    Research Scientist – SARS-CoV-2 Vaccine Development

    Ohio State University – Columbus, Ohio, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter